Cyclopharm Limited
ASX CYC.AX
Cyclopharm Limited Dividend Per Share for the year ending December 31, 2023: USD 0.01
-
Cyclopharm Limited Dividend Per Share for the year ending December 31, 2022 was USD 0.01, a -8.79% change year over year.
-
Cyclopharm Limited Dividend Per Share for the year ending December 31, 2021 was USD 0.01, a -5.43% change year over year.
-
Cyclopharm Limited Dividend Per Share for the year ending December 31, 2020 was USD 0.01, a 11.20% change year over year.
-
Cyclopharm Limited Dividend Per Share for the year ending December 31, 2019 was USD 0.01, a 0.79% change year over year.
| Date | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) |
|---|
Don’t Miss A Beat
| CEO | Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM |
| IPO Date | Jan. 17, 2007 |
| Location | Australia |
| Headquarters | 1 The Crescent |
| Employees | 87 |
| Sector | Healthcare |
| Industries | |
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Past 5 years
USD 0.74
StockViz Staff
February 6, 2025
Any question? Send us an email